By Benjamin Horney ( July 27, 2016, 5:34 PM EDT) -- Shanghai Fosun Pharmaceutical Group Co. Ltd. is putting the finishing touches on a deal to acquire a controlling stake in India-based drugmaker Gland Pharma Ltd., the Economic Times reported on Wednesday. According to the report, the deal will be worth $1.4 billion, and an official announcement could come any day now. Reports in April said Gland Pharma was receiving a ton of interest from multiple suitors, including Advent International and Baxter International. KKR & Co., together with Gland Pharma's founders, hold a roughly 96 percent ownership in the drugmaker....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.